A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles

Aguirre, 2016, Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting, Cancer Discov., 6, 914, 10.1158/2159-8290.CD-16-0154 Berger, 2016, High-throughput Phenotyping of Lung Cancer Somatic Mutations, Cancer Cell, 30, 214, 10.1016/j.ccell.2016.06.022 Brum, 2015, Connectivity Map-based discovery of parbendazole reveals targetable human osteogenic pathway, Proc. Natl. Acad. Sci. USA, 112, 12711, 10.1073/pnas.1501597112 Carlino, 2013, Antiproliferative effects of continued mitogen-activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma, Mol. Cancer Ther., 12, 1332, 10.1158/1535-7163.MCT-13-0011 Churchman, 2015, Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia, Cancer Cell, 28, 343, 10.1016/j.ccell.2015.07.016 Corsello, 2017, The Drug Repurposing Hub: a next-generation drug library and information resource, Nat. Med., 23, 405, 10.1038/nm.4306 Davis, 2011, Comprehensive analysis of kinase inhibitor selectivity, Nat. Biotechnol., 29, 1046, 10.1038/nbt.1990 Dinwiddie, 2014, Recent evidence regarding triclosan and cancer risk, Int. J. Environ. Res. Public Health, 11, 2209, 10.3390/ijerph110202209 Dixit, 2016, Perturb-Seq: Dissecting Molecular Circuits with Scalable Single-Cell RNA Profiling of Pooled Genetic Screens, Cell, 167, 1853, 10.1016/j.cell.2016.11.038 Donner, 2012, Imputing gene expression from selectively reduced probe sets, Nat. Methods, 9, 1120, 10.1038/nmeth.2207 Dudley, 2011, Computational Repositioning of the anticonvulsant topiramate for inflammatory bowel disease, Sci. Transl. Med., 3, 10.1126/scitranslmed.3002648 Dyle, 2014, Systems-based discovery of tomatidine as a natural small molecule inhibitor of skeletal muscle atrophy, J. Biol. Chem., 289, 14913, 10.1074/jbc.M114.556241 Edgar, 2002, Gene Expression Omnibus: NCBI gene expression and hybridization array data repository, Nucleic Acids Res., 30, 207, 10.1093/nar/30.1.207 Farooq, 2009, p38 Mitogen-activated protein kinase stabilizes SMN mRNA through RNA binding protein HuR, Hum. Mol. Genet., 18, 4035, 10.1093/hmg/ddp352 Fortney, 2015, Prioritizing therapeutics for lung cancer: an integrative meta-analysis of cancer gene signatures and chemogenomic data, PLoS Comput. Biol., 11, e1004068, 10.1371/journal.pcbi.1004068 2015, Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans, Science, 348, 648, 10.1126/science.1262110 Hao, 2007, Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases, Mol. Cell, 26, 131, 10.1016/j.molcel.2007.02.022 Hast, 2014, Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination, Cancer Res., 74, 808, 10.1158/0008-5472.CAN-13-1655 Hughes, 2000, Functional discovery via a compendium of expression profiles, Cell, 102, 109, 10.1016/S0092-8674(00)00015-5 Illumina Inc. (2007). BeadStudio Normalization Algorithms for Gene Expression Data (Illumina Technical Bulletin Pub. No.470-2007-005). Jackson, 2003, Expression profiling reveals off-target gene regulation by RNAi, Nat. Biotechnol., 21, 635, 10.1038/nbt831 Järås, 2014, Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia, J. Exp. Med., 211, 605, 10.1084/jem.20131033 Johnson, 2007, Adjusting batch effects in microarray expression data using empirical Bayes methods, Biostatistics, 8, 118, 10.1093/biostatistics/kxj037 Kent, 2002, BLAT--the BLAST-like alignment tool, Genome Res., 12, 656, 10.1101/gr.229202 Krönke, 2015, Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS, Nature, 523, 183, 10.1038/nature14610 Lamb, 2006, The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease, Science, 313, 1929, 10.1126/science.1132939 Lantermann, 2015, Inhibition of Casein Kinase 1 Alpha Prevents Acquired Drug Resistance to Erlotinib in EGFR-Mutant Non-Small Cell Lung Cancer, Cancer Res., 75, 4937, 10.1158/0008-5472.CAN-15-1113 Litichevskiy, 2017, A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations, bioRxiv Liu, 2015, Treatment of obesity with celastrol, Cell, 161, 999, 10.1016/j.cell.2015.05.011 Locatelli, 2010, Transcriptional analysis of an E2F gene signature as a biomarker of activity of the cyclin-dependent kinase inhibitor PHA-793887 in tumor and skin biopsies from a phase I clinical study, Mol. Cancer Ther., 9, 1265, 10.1158/1535-7163.MCT-09-1163 Long, 2014, Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma, Nat. Commun., 5, 5694, 10.1038/ncomms6694 Massard, 2011, A first in man, phase I dose-escalation study of PHA-793887, an inhibitor of multiple cyclin-dependent kinases (CDK2, 1 and 4) reveals unexpected hepatotoxicity in patients with solid tumors, Cell Cycle, 10, 963, 10.4161/cc.10.6.15075 Muthuswami, 2013, Breast tumors with elevated expression of 1q candidate genes confer poor clinical outcome and sensitivity to Ras/PI3K inhibition, PLoS ONE, 8, e77553, 10.1371/journal.pone.0077553 O’Boyle, 2011, Open Babel: An open chemical toolbox, J. Cheminform., 3, 33, 10.1186/1758-2946-3-33 Peck, 2006, A method for high-throughput gene expression signature analysis, Genome Biol., 7, R61, 10.1186/gb-2006-7-7-r61 Rohban, 2017, Systematic morphological profiling of human gene and allele function via Cell Painting, eLife, 6, 10.7554/eLife.24060 Rosenbluth, 2008, A gene signature-based approach identifies mTOR as a regulator of p73, Mol. Cell. Biol., 28, 5951, 10.1128/MCB.00305-08 Rovedo, 2011, Inhibition of glycogen synthase kinase-3 increases the cytotoxicity of enzastaurin, J. Invest. Dermatol., 131, 1442, 10.1038/jid.2011.70 Saito, 2009, Chemical genomics identifies the unfolded protein response as a target for selective cancer cell killing during glucose deprivation, Cancer Res., 69, 4225, 10.1158/0008-5472.CAN-08-2689 Schneider, 2014, Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS, Cancer Cell, 26, 509, 10.1016/j.ccr.2014.08.001 Schnell, 2015, Therapeutic targeting of HES1 transcriptional programs in T-ALL, Blood, 125, 2806, 10.1182/blood-2014-10-608448 Seiler, 2008, ChemBank: a small-molecule screening and cheminformatics resource database, Nucleic Acids Res., 36, D351, 10.1093/nar/gkm843 Singh, 2016, PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma, PLoS ONE, 11, e0150836, 10.1371/journal.pone.0150836 Smith, 2017, Evaluation of RNAi and CRISPR technologies by large-scale gene expression profiling in the Connectivity Map, bioRxiv Stockwell, 2012, Mechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signalling, PLoS ONE, 7, e28568, 10.1371/journal.pone.0028568 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. USA, 102, 15545, 10.1073/pnas.0506580102 Tseng, 2005, Tight clustering: a resampling-based approach for identifying stable and tight patterns in data, Biometrics, 61, 10, 10.1111/j.0006-341X.2005.031032.x Tsherniak, 2017, Defining a Cancer Dependency Map, Cell, 170, 564, 10.1016/j.cell.2017.06.010 van der Maaten, 2008, Visualizing Data using t-SNE, J. Mach. Learn. Res., 9, 2579 Wagle, 2014, MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition, Cancer Discov., 4, 61, 10.1158/2159-8290.CD-13-0631 Wang, 2008, Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab, Mol. Cell. Biol., 28, 5605, 10.1128/MCB.00787-08 Wang, 2011, Expression-based in silico screening of candidate therapeutic compounds for lung adenocarcinoma, PLoS ONE, 6, e14573, 10.1371/journal.pone.0014573 Wawer, 2014, Toward performance-diverse small-molecule libraries for cell-based phenotypic screening using multiplexed high-dimensional profiling, Proc. Natl. Acad. Sci. USA, 111, 10911, 10.1073/pnas.1410933111 Yueh, 2014, The commonly used antimicrobial additive triclosan is a liver tumor promoter, Proc. Natl. Acad. Sci. USA, 111, 17200, 10.1073/pnas.1419119111 Zhang, 2015, Drug repositioning for diabetes based on ‘omics’ data mining, PLoS ONE, 10, e0126082, 10.1371/journal.pone.0126082